Cureatr, a real-time healthcare information service provider, today announced the appointment of Richard Resnick as Chief Executive Officer and member of its board of directors. Under Resnick’s leadership, Cureatr is broadening its offerings to meet the evolving needs of providers and patients alike.
Prior to joing Cureatr, Resnick serve as the CEO of VC-backed GQ Life Sciences, where he revitalized strategy to turn company around from a -44% to a 33% EBITDA margin and sold company for 10X EBITDA through competitive bidding process in October 2016. Resnick holds an M.B.A. from the MIT Sloan School of Management, an M.S. in Computer Science from Worcester Polytechnic Institute, and a B.S in Computer Science from the University of Massachusetts at Amherst.
“I was originally attracted to Cureatr because of its amazing people, its strong customer base, and its best-in-class technology,” said Resnick. “I cannot imagine a more impactful and exciting time to join Cureatr as we transform from a technology company to a better care company, dedicated to the bigger work of filling in the blanks that exist in healthcare for clinicians, hospitals and patient populations.”
Founded in 2012, Cureatr provides secure messaging and clinical transition notifications to improve patient care through stronger clinical communication and coordination.
